St. Rita’s Introduces UroNav to Help Detect Prostate Cancer
(Lima, September 27, 2016) September marks National Prostate Cancer Awareness Month. According to the Center for Disease Control and Prevention (CDC), aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. Knowing this, St. Rita’s Lima Urology has attained a new biopsy machine called the UroNav Fusion Biopsy System developed by the Invivo Corporation.
“This new technology will allow us to find and diagnose potentially hidden tumors much better,” said Dr. Craig Nicholson, Urologist at Lima Urology. “As a regional leader in prostate cancer care, we felt that utilization of this new technology, developed by the NIH, would help us continue to provide patient care that is second to none.”
Within the 10 county area, St. Rita’s is the first practice to introduce this new type of technology to patients.
When using UroNav, doctors take a high-field MRI image of the patient’s prostate gland. This aids in detecting suspicious and sometimes hidden lesions. The image is then fused with an ultrasound image to assist in identifying suspicious areas of the prostate for needle biopsy. The accuracy of this system helps eliminate taking multiple random biopsies, and may also allow us to discover aggressive tumors that may have been missed.
We are proud to bring this new technology to our community and to have the ability to better serve our patients, as well as provide a newer and more accurate way of diagnosing prostate cancer.
Editor’s Note: Dr. Craig Nicholson, Urologist at Lima Urology and an expert in prostate cancer care, will be available at 11 a.m. on Thursday, September 29 for interviews about UroNav and its impact on patient care.
For more information, please contact:
St. Rita’s Health Partners
C: 567- 242-4078